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ABSTRACT Equinatoxin II (EqtII), a protein toxin from the sea anemone Actinia equina, readily creates pores in
sphingomyelin-containing lipid membranes. The perturbation by EqtII of model lipid membranes composed of dimyristoyl-
phosphatidycholine and sphingomyelin (10 mol %) was investigated using wideline phosphorus-31 and deuterium NMR. The
preferential interaction between EqtII (0.1 and 0.4 mol %) and the individual bilayer lipids was studied by 31P magic angle
spinning NMR, and toxin-induced changes in bilayer morphology were examined by freeze-fracture electron microscopy. Both
NMR and EM showed the formation of an additional lipid phase in sphingomyelin-containing mixed lipid multilamellar
suspensions with 0.4 mol % EqtII. The new toxin-induced phase consisted of small unilamellar vesicles 20–40 nm in diameter.
Deuterium NMR showed that the new lipid phase contains both dimyristoylphosphatidycholine and sphingomyelin. Solid-state
31P NMR showed an increase in spin-lattice and a decrease in spin-spin relaxation times in mixed-lipid model membranes in the
presence of EqtII, consistent with an increase in the intensity of low frequency motions. The 2H and 31P spectral intensity
distributions conﬁrmed a change in lipid mobility and showed the creation of an isotropic lipid phase, which was identiﬁed as the
small vesicle structures visible by electron microscopy in the EqtII-lipid suspensions. The toxin appears to enhance slow
motions in the membrane lipids and destabilize the membrane. This effect was greatly enhanced in sphingomyelin-containing
mixed lipid membranes compared with pure phosphatidylcholine bilayers, suggesting a preferential interaction between the
toxin and bilayer sphingomyelin.
INTRODUCTION
Pore-forming peptides and proteins from the defense systems
of higher organisms, as well as many bacterial toxins, are
usually water-soluble molecules, which bind to their target
membranes then self-associate and translocate across the
lipid bilayer into transient or stable lytic pores (Dempsey,
1990; Menestrina et al., 1994; Broekaert et al., 1997; Minn
et al., 1997, Gouaux, 1997; Anderluh and Macek, 2002). The
action of such toxins can be investigated directly by studying
the changes they induce in the target membranes, as well
as the role the target lipid membrane constituents play in
the process of cell lysis. In some cases the presence of
speciﬁc molecular species in the target membrane is re-
quired for membrane recognition before pore-formation.
One such example includes the class of cholesterol-binding
toxins, which are highly hemolytic to mammalian cells while
providing self-immunity to the cholesterol-free bacterial
membranes of the source organisms (Bonev et al., 2001a).
Equinatoxin II (EqtII) is a 179-residue, 19.8-kDa cytolysin
isolated from the Mediterranean anemone Actinia equina L.
(Macek and Lebez, 1988). Analysis of the amino acid
(Simpson et al., 1990; Belmonte et al., 1994) and nucleotide
sequences of EqtII and other actinoporins (Anderluh et al.,
1996; Pungercar et al., 1997) showed no obvious similarity
to other pore-forming proteins and they appear to constitute
a novel family. These toxins are characterized by a high pI,
a molecular mass of ;20 kDa, afﬁnity for sphingomyelin
(SM) and permeabilizing activity in model lipid and cell
membranes (Zorec et al., 1990; Belmonte et al., 1993; Macek
et al., 1994). Recently the crystal (Athanasiadis et al., 2001)
and solution (Zhang et al., 2000; Hinds et al, 2002) structures
of EqtII have been reported. Although these structures pro-
vide clues as to which regions of EqtII might interact with
lipid membranes and undergo conformational changes, no
direct experimental evidence was obtained concerning the
conformational changes EqtII undergoes in reaching its
oligomeric state, or during its incorporation into the target
membrane.
EqtII-induced pore formation appears to involve the
monomer binding to the membrane (Macek et al., 1995),
followed by insertion and noncovalent oligomerization of
monomers into a pore with an effective inner hydrodynamic
radius of 1.1 nm (Belmonte et al., 1993). Analysis of the
dose-response relationship for EqtII and another SM-
preferring cytolytic toxin, sticholysin I, produces Hill
coefﬁcients of 3–4 (Michaels, 1979; Varanda and Finkel-
stein, 1980; Belmonte et al., 1993). Cross-linking experi-
ments on membranes (Belmonte et al., 1993) as well as
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kinetic measurements with sticholysin I (Tejuca et al., 1996)
suggest the existence of a trimer or tetramer in the structure
of the functional pore.
In principle, at least two steps are involved in formation of
the EqtII pore, initial binding of monomers to the membranes
and subsequent oligomerization into a functional pore.
However, it has been shown that the most abundant form
of the toxin on the membrane is the monomer and that
the fraction of toxin associated in pores is actually small
(Belmonte et al., 1993; Tejuca et al., 1996). At lipid/toxin
molar ratios of 400, ;80% of the protein was bound
(Anderluh et al., 1999), with 100–200 EqtII monomers
bound per unilamellar vesicle of ;100-nm diameter. Inter-
estingly, the number of pores determined from permeabili-
zation experiments was never higher than 2–3 per vesicle at
a total lipid/toxin ratio of 10 and would certainly be less at
a lipid/toxin ratio of 400 (Macek et al., 1995; Tejuca et al.,
1996). This clearly indicates that most of the toxin is not in
an oligomeric form. Hence, NMR studies of the interaction
of EqtII with lipid bilayers are likely to report on lipid-
protein interactions rather than pore formation.
The nature of the interaction between EqtII and the lipids
in bilayer membranes and, in particular, the speciﬁc role
of sphingomyelin in pore formation are poorly understood
(Bernheimer and Avigad, 1976; Tejuca et al., 1996). The
insertion of EqtII into phosphatidylcholine monolayers is
optimal when the SM content is 50% of the phospholipid
(Caaveiro et al., 2001), although one biological target of
EqtII, the red blood cell membrane, contains between 5 and
30 mol % SM.
The interaction of membrane water-soluble proteins with
speciﬁc lipids in model membranes has been investigated
previously using solid-state NMR techniques (Pinheiro and
Watts, 1994; Carbone and Macdonald, 1996; Bonev et al.,
2000a). Here we apply similar solid-state NMR methods
to study the interaction between EqtII and sphingomyelin-
containing bilayer lipid membranes, with the aim of elu-
cidating the nature of the lipid-toxin interaction and its role
in the pore-forming mechanism.
MATERIALS AND METHODS
Equinatoxin II
Equinatoxin II was prepared from sea anemone extracts as described by
Macek and Lebez (1988). Brieﬂy, sea anemones were gently squeezed and
the released liquid was collected. The obtained extracts were fractionated by
acetone precipitation. The precipitate obtained after ﬁnal concentration in
80% acetone was dissolved in 10 mM acetic acid and applied to a Sephadex
G50 (Sigma, St Louis, MO) column. Active fractions were pooled and
applied to a CM-cellulose (Sigma) column. Bound toxin was eluted using
a salt gradient. Active fractions were dialyzed three times against water and
the toxin was lyophilized. Lyophilized toxin was dissolved in a small
volume of distilled water and dialyzed a further three times against 5 L of
water to remove traces of salt and buffer. EqtII was lyophilized again and
stored as a dry powder at 208C until use.
Lipids
Brain sphingomyelin (Avanti Polar Lipids, Inc., Alabaster, AL) was used
as shipped without further puriﬁcation. Chain perdeuterated dimyristoyl-
phosphatidylcholine (DMPC-d54) was synthesized from perdeuterated
myristic acid by acylation of glycerophosphocholine (Sigma), as de-
scribed previously (Bonev and Morrow, 1997). The ﬁnal product was
puriﬁed on a silica gel, mesh 60, liquid chromatography column and
eluted with a 65:25:5 mixture of chloroform/methanol/28% ammonia.
The lipid was found to migrate as a single spot under thin layer chro-
matography. All NMR experiments were repeated using commercially
available DMPC-d54 (Avanti Polar Lipids Inc.) and similar results were
obtained.
Sample Preparation
For sample preparation, lipids (DMPC or 10 DMPC:1 SM mole ratio) were
mixed in a chloroform/methanol (2:1) system 10 mg/mL in a round-bottom
ﬂask. The solvent was subsequently removed using a rotary evaporator and
the lipid mixtures were dried under high vacuum for 3–5 h. Lyophilized
EqtII was dissolved in water at a concentration of 2 mg/ml (pH ;6.5) and
appropriate amounts used to give the desired toxin-lipid ratio (e.g. 1000
DMPC:100 SM:1 EqtII or 1000 DMPC:1 EqtII). Approximately 30 mg of
the lipid mixtures were hydrated in 1.0 mL of toxin in deionised water. Each
sample was subsequently put through ﬁve cycles of rapid freezing in liq-
uid nitrogen and equilibrating at 508C. The multilamellar vesicle (MLV)
suspensions were then concentrated in a Beckman bench top centrifuge
(20,000 rpm, 20 min, 48C). The pellet was loaded directly into 4 mm or
5 mm NMR zirconia rotors for the Magic Angle Spinning (MAS) experi-
ments or 5 mm Pyrex NMR tubes for static wideline measurements.
NMR spectroscopy
Phosphorus-31 wideline and MAS NMR measurements were carried out on
CMX Inﬁnity 200 and 500 spectrometers (Chemagnetics, Varian, Palo Alto,
CA) at proton frequencies of 200 and 500 MHz, respectively. Typically
20 mmol of phospholipid dispersions were packed in 4-mm rotors for use
with either a 200 MHz CP probe (Bruker Spectrospin, Etlingen, Germany)
or a 500 MHz Apex (Chemagnetics) CP MAS probe. A single 31P 908 pulse
was used for excitation, with broadband decoupling at the proton frequency
during acquisition. The 908 pulse length was 4 ms, and the strength of the
proton decoupling ﬁeld was 20 kHz. The dwell time was 20 ms and 2048
points were collected in each experiment. Between 300 and 3000 transients
were averaged for each free induction decay during magic angle spinning
experiments and between 5000 and 10000 during wideline experiments,
with a 5 s delay (exceeding 53 T1) between acquisitions in all cases, where
T1 is the longitudinal relaxation time. The sample rotation speed was
maintained at 12 kHz during acquisition of the MAS spectra and the tem-
perature was 408C.
Variable-temperature experiments and 31P relaxation measurements were
carried out on a Varian Inova 300 NMR spectrometer equipped with a Doty
MAS probe (Doty Scientiﬁc Inc., Columbia, SC) operating at 121.5 MHz for
31P, as well as on the abovementioned CMX Inﬁnity 200 spectrometer. The
following conditions were used: sweep width 62.5 kHz, 908 pulse 3.2 ms,
recycle time 2 s, number of transients 2400–4196, line broadening 100 Hz
and a temperature range of 25–508C with 58C intervals. The spin-lattice
relaxation time, T1, was measured using the inversion recovery (p – t – p/2)
pulse sequence, with t values between 0.005 and 8.0 s. Spin-spin relaxation
time, T2, measurements were made using a spin-echo experiment (p/2 – t –
p) with t values between 0.1 and 5 ms to observe the decay in spectral
intensity. Duplicate experiments were run and relaxation times determined
by ﬁtting a single exponential to a plot of signal intensity against the delay
time t (Homans, 1992). Errors estimated from the residual spectral intensity
during spectral simulations were less than 62.5%.
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In the high resolution 31P MAS experiments, described here, the spectral
density function, J(v0), has a Lorentzian shape:
Jðv0Þ ¼ tc=ð11v20t2cÞ:
The spin-lattice relaxation rate, 1/T1, which is proportional to J(v0)
(Haeberlen and Waugh, 1969), is highest when the characteristic correlation
time of the dominant molecular motions equals the inverse of the Larmor
frequency, tc ¼ 1/v0. Shifts in the T1 minimum, are, therefore, indicative of
changes in the rate of molecular motions. Also, an order of magnitude
estimate of tc can be obtained (;10 ns for
31P v0 of 81 MHz).
Deuterium NMR experiments were performed using a Chemagnetics
Inﬁnity 400 spectrometer at proton frequency of 398 MHz. A quadrupole
echo sequence (p/2 – t – p/2– t – acquisition) (Davis et al., 1976) was
used with interpulse delay t of 40 ms. The 908 pulse length was 4 ms and the
repetition time was 0.5 s. Between 1024 and 96000 transients were averaged
per free induction decay.
The quadrupole splitting, observed from each deuterated methylene
segment, is related to the mean orientational order parameter of this segment
as follows:
DnQ ¼ 3=4ðe2qQ=hÞ3 SCD
and is a sensitive probe for detecting changes in the overall order of
the phospholipids chains. The quantity in brackets is the carbon-deuterium
quadrupole coupling constant, equal to 167 kHz for C–D bonds (Seelig,
1977). Variable temperature 2H spectra were acquired between 25 and 508C
with a 58C interval using a Varian Inova 300 NMR spectrometer equipped
with a Doty 5-mm probe (Doty Scientiﬁc Inc.). The 2H operating frequency
was 46.1 MHz and the following parameters were used: sweep width 180
kHz, p/2 pulse 5.6 ms, recycle time 0.3 s, t 40 ms, number of transients
3200–8096, and line broadening 50 Hz.
Electron microscopy
Samples of DMPC/SM/EqtII were equilibrated at room temperature and
quenched for freeze-fracture by rapid (;104–105 8C/s) immersion into liquid
butane (Severs et al., 1995; Shotton and Severs, 1995). The immobilized
frozen samples were fractured at 1008C, Pt shadowed at angles of 458 and
a carbon ﬁlm was subsequently applied perpendicular to the fracture plane in
a Balzers (Liechtenstein) freeze-etching apparatus. Residual sample was
removed using consecutive washes in potassium hypochlorate, water, and
methanol. The carbon-platinum replicas were transferred from a ﬁnishing
water bath onto copper electron microscope grids. Micrographs were
acquired using a Phillips (Netherlands) CM120 transmission electron
microscope at 100 kV cathode voltage.
RESULTS
Phosphorus-31 wideline NMR
The effect of EqtII on phospholipid phase behavior was
investigated using wideline 31P NMR. Spectra from DMPC
and from a DMPC-SM (10:1 mol ratio) mixture in water at
25 and 408C without EqtII are shown in Fig. 1, a and f, and
Fig 1, b and g, respectively. These spectra are very similar
and consist of powder distributions dominated by the ef-
fective chemical shift anisotropy (CSA) of the lipid phos-
phates. The observed spectral width of ;42 to 48 ppm
reﬂects partial motional averaging of the 31P CSA due to
fast axial rotation of the phospholipid molecules, which is
characteristic of the ﬂuid bilayer phase. A single powder
pattern is observed in each case, which suggests that the lipid
FIGURE 1 Phosphorus-31 wideline NMR
spectra from hydrated DMPC/SM/EqtII sus-
pensions at 258C: (a) DMPC; (b) 1000 DMPC:
1 EqtII; (c) 1000 DMPC: 100 SM; (d ) 1000
DMPC: 100 SM: 1 EqtII; and (e) 1000 DMPC:
100 SM: 4 EqtII; and at 408C: ( f ) DMPC; (g)
1000 DMPC: 1 EqtII; (h) 1000 DMPC: 100
SM; (i) 1000 DMPC: 100 SM: 1 EqtII; and ( j )
1000 DMPC: 100 SM: 4 EqtII. The acquisition
parameters are described in Materials and
Methods.
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species are well mixed in the bilayer and the average size of
the lipid aggregates exceeds 1 mm. This is a good indication
that the sample is, indeed, an MLV dispersion (Seelig, 1978).
Addition of either 10% SM (Fig. 1 b) or 0.1% EqtII
(Fig. 1 c) to pure DMPC bilayers resulted in a decrease of
the effective phosphorus CSA from;47 ppm for pure DMPC
to ;43 ppm in both cases. The effect of both additives,
therefore, amounts to a slight perturbation in the packing of
the bilayer phospholipids. After addition of both 10% SM
and 0.1% EqtII at 258C (Fig. 1 d ), however, the observed
effective CSA was ;47 ppm, which was comparable to that
of pure DMPC at 258C. The action of 0.1% EqtII on the
mixed lipid bilayer system at 408C (Fig. 1 i) led to the
formation of an additional lipid phase.
The increase in the overall effective 31P CSA of the mixed
lipid bilayer phosphates (DMPC/SM/EqtII, 1000:100:1 mo-
lar parts) at 258C is close to that observed in a pure DMPC
bilayer. This combined effect of EqtII and SM is consistent
with the formation of SM-rich/EqtII lateral domains, sur-
rounded by a DMPC-rich, SM-depleted lateral bilayer phase.
This phase is in thermodynamic equilibrium with the SM-
rich proteolipid bilayer domains and its spectral features dom-
inate the intensity distribution in the spectrum of Fig. 1 d.
Spectra of DMPC/SM (10:1 molar parts) and 0.4% EqtII
at both 258C and 408C are characterized by a dramatic
increase in the isotropic 31P line width, seen in the poorly
deﬁned 0 and 908 edges of the 31P wideline NMR spectra
(Fig. 1, e and j ), and an overall shape of the wideline
intensity distribution which is usually associated with the
formation of a gel phase (Fig. 1, e and j ) (Seelig, 1978). In
addition, at 408C the presence of 0.4% EqtII leads to the
formation of an additional phase, which is observed in the
spectral feature at 0 ppm (Fig. 1 j ). The phospholipid
structures in this phase undergo fast isotropic motions, which
average out completely the phosphate CSA. The spectral
contribution from the new phase was greater in the presence
of 0.4% than 0.1% EqtII (cf. Fig. 1, j and i, respectively).
Deuterium wideline NMR
In a set of experiments, parallel to the wideline 31P mea-
surements described above, chain perdeuterated DMPC was
used to investigate the effect of EqtII on chain order and
mobility. The spectra from DMPC in the ﬂuid bilayer phase
(Fig. 2, a and f ) consist of superimposed powder doublets
with quadrupole splittings not exceeding 33.4 kHz at 258C
and 27.8 kHz at 408C. After addition of 0.1 molar % EqtII the
observed maximum quadrupole splitting was reduced to
;29.6 kHz at 258C and 25.9 kHz at 408C (Table 1). This
reduction in lipid chain order most likely reﬂects incor-
FIGURE 2 Deuterium wideline NMR
spectra from hydrated DMPC/SM/EqtII sus-
pensions at 258C: (a) DMPC; (b) 1000
DMPC: 1 EqtII; (c) 1000 DMPC: 100 SM;
(d) 1000 DMPC: 100 SM: 1 EqtII; and (e)
1000 DMPC: 100 SM: 4 EqtII; and at 408C:
(f ) DMPC; (g) 1000 DMPC: 1 EqtII; (h) 1000
DMPC: 100 SM; (i) 1000 DMPC: 100 SM: 1
EqtII; and ( j ) 1000 DMPC: 100 SM: 4 EqtII.
The acquisition parameters are described in
Materials and Methods.
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poration of toxin. Since the character of the spectra appears
to remain basically unchanged there is no evidence of any
speciﬁc interaction between the toxin and DMPC-d54.
The mixed lipid system, consisting of 10:1 molar parts
DMPC-d54/SM, was in the ﬂuid bilayer phase at both 25 and
408C. The observed maximum deuterium quadrupole split-
tings (Fig. 2, c and h) were 29.1 kHz at 258C and 26.8 kHz at
408C. The slight reduction in overall chain order can be at-
tributed to a perturbation of DMPC-d54 chain packing by SM.
The effect of 0.1 molar % EqtII on the PC/SM lipid
mixture was manifested in a slightly different manner in the
deuterium spectra at 25 and 408C. At 258C the presence of
toxin led to a reduction in the deuterium spectral width from
33.4 to 29.7 kHz. Interestingly, the overall width was slightly
greater than that from DMPC-d54 mixtures with either SM or
EqtII (29.6 and 29.1 kHz, respectively).
At 408C a new phase was formed, the existence of which
was manifested in the deuterium NMR spectra as an isotropic
line at zero quadrupole splitting (cf. 31P wideline, above and
EM results, below). The overall spectral width was reduced
to 26.6 kHz in comparison with pure DMPC-d54 (27.8 kHz).
The maximum quadrupole splitting fell between that from
DMPC-d54/SM (25.9 kHz) and DMPC-d54/EqtII (26.8 kHz),
which suggests the mixed effect of both additives on the
DMPC-d54 reporter molecules.
One possible explanation for the spectral features in Fig. 2,
d and i is that the temperature range of the PC/SM ﬂuid-gel
coexistence region is extended toward higher temperatures
by the presence of EqtII. At 258C the ﬂuid bilayer component
is within this region and consists of two sub-phases, a ﬂuid
DMPC-d54-rich sub-phase and an SM-rich sub-phase. The
maximum spectral width is dominated by the order in the
DMPC-d54-rich sub-phase, as it sequesters preferentially the
reporter lipid. At 408C the bulk bilayer lipid is in the ﬂuid
phase and such demixing does not take place. This effect
of EqtII was conﬁrmed by differential scanning calorimetry,
which showed an elevation of the main gel-ﬂuid lipid phase
transition from 208C for the deuterated DMPC-d54 sample to
218C and a slight broadening with 10% SM or 0.1% EqtII
(data not shown). When EqtII was added to DMPCwith 10%
SM, the phase transition broadened signiﬁcantly and, for the
1000 DMPC: 100 SM: 4 EqtII sample, extended over the
range 20–358C.
This EqtII-induced lateral domain formation and phase
separation is enhanced by increasing the toxin concentra-
tion to 0.4 mol %. At 258C this results in a shift of the lipid
phase coexistence in favor of the motionally restricted
low temperature phase and an enhanced transverse relaxation
of the chain methylene deuterons (Fig. 2 e). In addition,
a small fraction of the lipid phase with isotropic spectral
features is also formed. At 408C the relative fraction of this
new phase is strongly enhanced, as is the transverse re-
laxation rate R2 (Fig. 2 j). The deuterium T2 also appears to
depend on the methylene position within the acyl chains
(cf. Bonev and Morrow, 1996). Two phenomena could be
taking place simultaneously: 1), lateral phase separation
within the bilayer, due to segregation of SM by EqtII, and 2),
phase separation, resulting from withdrawal of lipid material
from the bilayer into SUVs or similar proteolipid structures
by EqtII. The ﬁrst effect would manifest itself in changes of
the observed maximum quadrupole splitting, and the second
would result in the presence of an isotropic peak.
Electron Microscopy
Freeze-fracture electron micrographs from DMPC/SM/EqtII
(mole ratio 1000:100:4) MLVs, ﬂash-frozen from 308C, are
shown in Fig. 3. The most prominent features in the
micrographs are 300 to 500 nm MLVs frozen from the
rippled Pb9 phase, which coexist with a large number of very
small, most probably unilamellar, vesicles with diameter
varying between 20 and 40 nm. These structures were not
present in DMPC/EqtII or DMPC/SM samples (data not
shown). The multilamellar character of the primary lipid
population is observed in multiple jagged edges traversing
the fractured faces of the MLVs (Fig. 3 a). The entire surface
of the MLVs is rippled with periodicity of ;70 A˚, which is
characteristic of the Pb9 phase (this effect was seen also in
the DMPC/SM and DMPC/EqtII samples). One interesting
feature of the MLV surface topography is the unusually
irregular relief. A large number of smaller diameter,
spherical structures appear trapped in the interior of larger
diameter vesicles (Fig. 3 c). Imprints from objects of the
same size as the small lipid structures are visible on the
surfaces of the MLVs (Fig. 3 b). The cross section of the
MLV walls appears swollen, unlike the regular and periodic
lamellar packing observed in pure lipid systems (not shown).
A number of small vesicles appear to bud off from the MLV
surfaces (Fig. 3 c); and imprints from vesicles removed by
fracture are visible, Fig. 3 b). The small unilamellar lipid
population most likely originates from the MLVs, the la-
mellae of which have been destabilized by the toxin. Lipid
material has been withdrawn from the low curvature MLV
surfaces into highly curved proteolipid structures in a simi-
lar manner to the changes in the lipid bilayer observed dur-
TABLE 1 Phosphorus-31 MAS NMR transverse relaxation
times and maximum deuterium quadrupole splittings from
pure and mixed lipid membranes with and without EqtII
31P MAS
T2 6 0.15 [ms]
2H static,
DnQ 6 0.2 [kHz]
Sample (mol:mol) 258C 408C 258C 408C
DMPC 3.7 ms 3.5 ms 33.4 kHz 27.8 kHz
1000 DMPC: 100 SM 2.7 ms 3.6 ms 29.6 kHz 25.9 kHz
1000 DMPC: 1 EqtII 2.8 ms 3.5 ms 29.2 kHz 26.8 kHz
1000 DMPC: 100 SM: 1 EqtII 1.7 ms 3.4 ms 29.7 kHz 26.6 kHz
1000 DMPC: 100 SM: 4 EqtII 1.1 ms 3.8 ms n/d* 26.8 kHz
*Spectral intensity distribution does not reﬂect purely axially-symmetric
lipid motions and DnQ cannot be determined in a simple way.
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ing membrane perturbation by pneumolysin (Bonev et al.,
2000b, 2001a). The presence of MLVs was also reﬂected in
the observed wideline 31P-powder patterns and 2H- quad-
rupolar splittings (Davis et al., 1976), while the SUV
population gave rise to the isotropic lines seen at;0 ppm in
both 31P and 2H NMR wideline spectra (Figs. 1 and 2).
A close examination of the small vesicle surfaces reveals
the presence of an unusual soccer ball pattern, distinctly
different from the 70-A˚ ripple on the MLV surfaces. This
pattern reﬂects the different lipid and protein packing on
the surface of the small lipidic particles. A sucrose density
gradient (0–50%) centrifugation revealed the presence of an
extra band in the DMPC/SM/EqtII sample in addition to the
major fraction, which appeared at the same position as the
MLV band of the control DMPC/SM sample (1.105 gm/mL
density). The additional layer in the EqtII-containing sample
was at 1.030 gm/mL, corresponding approximately to the
expected position of protein-free SUV (Watts et al., 1978).
Interestingly, similar small lipid structures are observed by
the action of EqtII on V-79 cells (Batista and Jezernik, 1992).
Phosphorus-31 MAS NMR
Changes in the individual lipid species within the bilayer
caused by EqtII can be monitored simultaneously by using
high-resolution solid-state 31P MAS NMR, which allows for
each lipid component to be resolved by its isotropic chemical
shift (Pinheiro and Watts, 1994). Such changes have been
observed previously during the interaction of other peptides
and proteins with lipid membranes (Pinheiro and Watts,
1994; Carbone and Macdonald, 1996; Bonev et al., 2000a,
2001a).
The 31P MAS NMR spectrum from a lipid mixture of
DMPC/SM in a 10:1 mole ratio after a single-pulse exci-
tation is shown in Fig. 4 a. The individual spectral contribu-
tions from PC at 0.87 ppm and SM at 0.24 ppm are well
resolved and their spectral intensities reﬂect the molar ratio
of each lipid in the mixture. Two high-resolution 31P MAS
NMR spectra were acquired from the same lipid mixture
containing 0.4% EqtII (PC/SM/EqtII mole ratio of 1000:
100:4). One spectrum (Fig. 4 b) was acquired from the pel-
let collected after bench top centrifugation and one from the
supernatant (Fig. 4 c). The spectrum from the pellet had
a shape very similar to that of the spectrum of Fig. 4 a with
both resonances slightly shifted upﬁeld to0.74 ppm for PC
and to 0.13 ppm for SM, respectively. A similar upﬁeld
shift has been observed after membrane association of
peptides and reﬂects subtle changes in the membrane surface
charge density (Bonev et al., 2001b). A single line of low
intensity and a chemical shift of 0.16 ppm was observed in
the 31P MAS NMR spectrum from the supernatant (Fig. 4 c).
This most probably originates from small toxin-rich, and
possibly SM-enriched, vesicles that were also observed in
the electron micrographs and in the minor isotropic spectral
component of the wideline 31P and 2H NMR spectra. This is
in agreement with the relatively low intensity of the 31P MAS
NMR line compared to the total spectral intensity from the
bilayer phospholipids from the pellet (Fig. 4 b).
FIGURE 3 Freeze-fracture electron micrographs of hydrated DMPC/SM/
EqtII (1000:100:4 mol ratio) suspension (from top to bottom): (a) 46,0003
magniﬁcation; (b) 130,0003 magniﬁcation; and (c) another view at
46,0003 magniﬁcation.
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Variable temperature 31P MAS NMR
The temperature dependence of 31P MAS longitudinal re-
laxation times in pure and mixed lipid bilayers with and
without EqtII was investigated between 208C and 508C at
200 MHz proton frequency (81 MHz Larmor frequency for
31P). The 31P spin-lattice relaxation times, T1, of each bilayer
phospholipid constituent were determined simultaneously
from the high resolution MAS NMR spectra. As the
temperature was varied between 208C and 508C, T1 in-
creased from 1.1 to 1.6 s (Table 2) in pure DMPC bilayers
(Fig. 5, solid diamonds), which suggests that the principal
mode of lipid motions is in the fast regime. The small
temperature variation of T1 indicates the proximity to a T1
minimum, which agrees with earlier relaxation measure-
ments in mixed PC bilayers (Seelig, 1978; Milburn and
Jeffrey, 1987). At 208C, just below the phase transition, T1
increases, leaving a discontinuous change, possibly, into
a slow motions regime. This is the case for SM bilayers, as
well, where the T1 discontinuity is observed around 408C,
near the gel-ﬂuid phase transition temperature (Fig. 5, solid
squares). The 31P T1 takes a minimal value of 1.1 s between
408C and 458C and increases from 1.5 to 1.8 s as the
temperature is lowered from 358C to 208C into the gel phase,
which suggests that the molecular dynamics of SM is slightly
slower than that of DMPC.
The individual lipid components in a mixed lipid bilayer
of 10:1 molar ratio DMPC/SM could not be resolved in the
MAS NMR spectrum. The overall T1 and its variation with
temperature followed closely those of pure DMPC, which is
expected from the large fraction of this lipid in the mixture
(Fig. 5, solid triangles) and shows no speciﬁc perturbation of
the DMPC dynamics by SM.
The longitudinal relaxation times from DMPC bilayers in
the presence of 0.1 mol % EqtII were also very similar to
those from the pure lipid. At higher temperatures a small
decrease in T1 was observed, compared to that from pure
DMPC, suggesting a possible shift in the T1 minimum
toward a higher temperature and, therefore, lower rates of
lipid motions in the presence of the toxin. This apparent
contradiction with the decrease observed by 2H NMR in the
acyl chain orientational order may reﬂect a direct interaction
between EqtII and the hydrophobic interior of the bilayer,
which increases the orientational disorder in the chain
methylenes but otherwise hinders the axial reorientation of
the DMPC molecules.
In the case of mixed PC/SM (10:1 molar ratio) lipid
bilayers with 0.4 mol % EqtII the individual spectral con-
tributions from the two lipids were well resolved. The re-
laxation behavior of DMPC was practically identical to that
of pure DMPC bilayers. In contrast, the SM T1 increased in
comparison to pure SM bilayers in the ﬂuid phase from
;1.2–1.5 s and showed very little variation over the entire
temperature interval. It remained lower than the 1.8 s value,
measures from gel SM bilayers. These changes in the
relaxation behavior of the two lipids are consistent with the
FIGURE 4 Phosphorus-31 MAS NMR at 408C and 12 kHz spinning
speed (500 MHz proton frequency) spectra from DMPC/SM mixtures in
a MLV suspension: DMPC/SM (10:1 mol ratio) (a), and DMPC/SM /EqtII
(1000:100:4 mol ratio) following 20 min benchtop centrifugation to produce
a pellet (b), and supernatant (c).
FIGURE 5 Phosphorus-31 longitudinal relaxation time, T1, as a function
of temperature recorded at 81 MHz from DMPC bilayers (¤), SM bilayers
(n), PC in 1000 DMPC: 100 SM bilayers (m), PC in 1000 DMPC: 4 EqtII
bilayer mixtures (e), PC in 1000 DMPC: 100 SM: 4 EqtII bilayer mixtures
(3) and SM in 1000 DMPC: 100 SM: 4 EqtII bilayer mixtures (). The
acquisition parameters are described in Materials and Methods.
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presence of proteolipid EqtII/SM complexes within the lipid
bilayer, surrounded by a DMPC-rich ﬂuid matrix. The SM
mobility is much reduced in comparison to that in ﬂuid SM
membranes. A slight rise in the SM T1 at lower temperatures
reﬂects the excess SM, which may order around the pro-
teolipid complexes.
Transverse relaxation
The 31P spectra of hydrated lipid bilayers at 258C (Fig. 1,
a–e) indicate that the presence of either SM or EqtII causes
a small change in lipid mobility and an increase in the
observed isotropic line width. This is supported by magic
angle spinning 31P data (not shown), which show a decrease
(by; 25%) in T2 relaxation time from 3.7 ms to 2.7–2.8 ms
when SM or EqtII is present (Table 1). This change is more
pronounced when EqtII was added to samples containing
SM. For the sample 1000 DMPC:100 SM:1 EqtII (Fig. 1 d ),
T2 decreased further (by approx. 30%) to 1.7 ms. When the
EqtII concentration was increased (1000 DMPC:100 SM:4
EqtII, Fig. 1 e), a more dramatic change in line shape was
observed and T2 decreased to 1.1 ms (Table 1). This change
in lipid mobility was also supported by a threefold change in
the MAS NMR spectral line width. The 31P spectrum (Fig.
1 e) shows a characteristic T2 broadening and is indicative of
a gel or Pb9 phase, as observed in DMPC-SM mixtures
(Lentz et al., 1981).
The spectra, shown in Fig. 1, a–d, are typical of phos-
pholipids in the ﬂuid La phase, which is also reﬂected in
the 31P MAS NMR relaxation times (T2 and T1) reported in
Table 1 and Fig. 5. The presence of EqtII decreased T1 for
the DMPC in ﬂuid phase samples (Fig. 5) but there was little
effect on T2, which remained in the range 3.4–3.8 ms at the
higher temperature (408C, Table 1), similar to the value
obtained for pure DMPC at 258C (already in the ﬂuid phase).
The slight increase in 31P T2 of the 1000 DMPC:100 SM:4
EqtII system probably reﬂects a contribution from the
isotropic phase. The decrease in T1 at higher temperatures
with EqtII in DMPC/SM dispersions is due to a more efﬁ-
cient relaxation mechanism on the MHz timescale, resulting
from a reduction in the rates of high frequency (; ns)
motions in the ﬂuid phase and consistent with an increase in
low frequency motions when the toxin is present (Cornell
et al., 1983).
DISCUSSION
EqtII, for which only a partial insertion into the bilayer has
been demonstrated (Hong et al., 2002), is a potent cytolytic
agent, which is active at nM concentrations (Anderluh and
Macek, 2002). At concentrations of 0.1 and 0.4 mol %, EqtII
had a similar effect on DMPC bilayers to that of the integral
membrane peptide gramicidin at concentrations of 16 mol %
(Cornell et al., 1988). However, the relative molecular
weight of gramicidin A (1882) is approximately ten times
lower than that of EqtII (;20 kDa). So even if we scale for
EqtII molecular weight relative to gramicidin A, we observe
a similar effect on lipid bilayers for EqtII but at an order of
magnitude lower protein mass. Although gramicidin is fully
incorporated into the lipid bilayer, it is unlikely that this
would be the case for EqtII for which only partial insertion
into the lipid membrane is expected (Hong et al., 2002).
Similarly, melittin, a lytic peptide from bee venom, at much
higher concentrations (10 mol %) than EqtII in DMPC bi-
layers produces an increase in low-frequency motions and
bilayer disruption (Smith et al., 1992). In comparison to
many known membrane-perturbing peptides (e.g. magainins,
tachyplesins, melittin, etc.) (Matsuzaki, 1998; Bechinger,
1999), EqtII has a far more disruptive effect on lipid bilayers
at much lower concentrations.
Although only part of the EqtII molecule is likely to
penetrate the lipid bilayer, EqtII inﬂuences the dynamics of
all lipid molecules, causing over 10% of the phospholipid
(estimated from the 2H isotropic component at 458C) to form
a separate phase. This isotropic spectral component can be
attributed to the presence of small vesicles, which were
observed by EM. Pure DMPC vesicles of 10-nm radius, as
a result of their decreased density and size compared with
extended MLV (Watts et al., 1978), would not spin down in
a bench centrifuge (Cornell et al., 1982) of the type used
for MLV sample preparation. Thus, the small structures
resulting from the action of EqtII on the MLV suspension
must be more dense than pure DMPC SUVs and rich in
EqtII. These EqtII-enriched proteoliposomes occur only
when SM is present in the target membrane and appear to be
a consequence of the EqtII-induced changes in the lipid.
Features characteristic of ﬂuid-phase bilayers were seen at
408C in both 31P and 2H wideline NMR spectra. In the
presence of 10% SM, addition of EqtII triggered the for-
mation of an isotropic component, the spectral contribution
of which increased with increasing temperature and toxin
concentration (Figs. 1 and 2). The main transition tempera-
ture for hydrated deuterated DMPC bilayers is ;208C
(Bonev and Morrow, 1997), and Tm for SM is around 408C
(Marsh, 1990). Further addition of EqtII to the DMPC-SM
TABLE 2 Phosphorus-31 MAS NMR longitudinal relaxation
times, T1, from pure and mixed lipid membranes with and
without 0.4% EqtII as a function of temperature recorded at 81
MHz phosphorus Larmor frequency. All lipid ratios are mol:mol
T1 6 0.03 (s)
Sample (mol:mol) 208C 258C 308C 358C 408C 458C 508C
DMPC 1.3 1.1 1.3 1.4 1.4 1.6 1.6
SM 1.8 1.8 1.7 1.5 1.2 1.2 1.3
1000 DMPC: 100 SM 1.3 1.3 1.3 1.4 1.4 1.5 1.5
1000 DMPC: 4 EqtII 1.2 1.3 1.3 1.4 1.5 1.6 1.6
1000 DMPC: 100 SM: 4
EqtII (PC peak)
1.2 1.1 1.3 1.3 1.4 1.3 1.5
1000 DMPC: 100
SM: 4 EqtII(SM peak)
1.5 1.5 1.4 1.5 1.5 1.5 1.5
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bilayer system resulted in a two-component 31P NMR spec-
trum at 408C (Fig. 1 j) where a broad isotropic line at;0 ppm
was superimposed onto the powder pattern of Fig. 1 f.
A similar isotropic feature was also observed in the 2H
wideline NMR spectra, acquired under similar conditions.
This feature at nearly 0 ppm reﬂects almost complete mo-
tional averaging of the effective 31P CSA of the lipid phos-
phates and points to the possible formation of very small
lipid structures (diameter\ 100 nm). The presence of such
small structures was veriﬁed by EM. The deuterium NMR
spectra acquired at 408C also showed an increased fraction
of the isotropic spectral component (at zero quadrupole
splitting) superimposed onto the powder pattern (Fig. 2 j),
which emphasizes the role EqtII plays in the formation of the
new lipid phase. Since the deuterium spectra are from the
labeled DMPC, this new lipid phase is not composed of SM
alone. Since the spectral features of the bilayer and the
nonbilayer phases are well resolved, the phospholipids in the
non-bilayer phase must be in slow exchange (exchange time
[ms) with the prevailing bilayer phase.
The 31P MAS longitudinal relaxation times of pure PC and
pure SM bilayers showed a discontinuity across the lipid
main transition (Fig. 5). Although T1 of pure DMPC bilayers
in the ﬂuid phase remained almost unaffected by the addition
of 0.4% toxin, the T1 change across the lipid main transition
disappeared. In contrast, addition of 0.4% EqtII to mixed
DMPC:SM bilayers lead to a pronounced increase in SM T1
from 1.2 to 1.5 s in the ﬂuid phase and a somewhat smaller
decrease in the PC T1, from 1.5 to 1.4 s. The longitudinal
relaxation of SM in a mixed lipid bilayer of 1000:100:4,
PC:SM:EqtII remained essentially unaffected by tempera-
ture, whereas that of PC followed the temperature behavior
of pure PC bilayers. This leads to a model where SM is
preferentially engaged by the toxin into lateral proteolipid
membrane domains, while PC exists in a lipid mixture,
effectively segregated away from the protein within the
bilayer.
In contrast to gradient centrifugation, which focuses the
different lipid dispersions into isopicnic bands, the observa-
tion of phospholipid in the supernatant from DMPC:SM:Eq-
tII (1000:100:4 mol ratio) after bench top centrifugation
probably results from the gentle conditions during the pre-
cipitation process. This incomplete precipitation of the pro-
teolipid suspension during sample preparation has prevented
us from applying the quantitative analysis of the protein/lipid
content, which was implemented for pneumolysin (Bonev
et al., 2001a). In the latter case precipitation was facilitated
by two additional factors—the presence of a toxin-induced
lipid aggregation and the enormity of the pneumolysin
oligomers (;3 MDa).
Two phenomena appear to take place in mixed PC/SM
bilayers when EqtII is present at 0.1 to 0.4%. Firstly, we
propose that a lateral phase separation occurs: the toxin ap-
pears to engage bilayer SM into lateral domains, enriched in
this lipid, which are surrounded by SM-depleted DMPC bi-
layer phase. Such demixing, which can be inferred from the
changes in the deuterium quadrupole splittings and 31P ef-
fective CSA, as well as from the temperature dependence of
31P T1, may not require the disruption of the bilayer struc-
tures. Secondly, a true three-dimensional phase separation
appears to be induced by EqtII, where the presence of toxin
leads to the formation of highly curved, possibly bilayer
structures, which are topologically disconnected from the
bulk bilayer phase. Such phase would lead to the presence of
an isotropic feature in the wideline 31P and 2H NMR spectra.
It appears as a distinct resonance in the 31P MAS NMR
spectra at chemical shift, different from these of the bilayer
lipids and is seen in the electron micrographs as small,
possibly unilamellar, structures, budding off the bulk MLV
lipid. The formation of small structures of similar nature has
also been observed during the action of fusion peptides
interacting with lipid bilayers (Agirre et al., 2000; Batista
and Jezernik, 1992).
Caaveiro et al., (2001) have shown that EqtII is sig-
niﬁcantly more effective when inducing leakage in DMPC
vesicles containing SM or cholesterol than in vesicles of pure
DMPC. Cholesterol has an ordering effect on lipid bilayers
(Lentz et al., 1981) and its role in enhancing the toxic action
of EqtII is unclear. Some clues might be sought from the
action of cholesterol-binding toxins, where cholesterol is
proposed to mediate self-association of the toxin in the target
membrane. The isotropic peak seen by both 31P and 2H NMR
could be taken as evidence of bilayer disruption and/or
membrane lysis.
EqtII, like other actinoporins, appears to recognize SM
both at the level of the headgroup, as indicated by the fact
that SM analogs with a modiﬁed phosphoric group are
resistant to these toxins (Meinardi et al., 1995), and by the
ceramide moiety because the ganglioside GM 1, with the
same ceramide moiety as SM, could mimic its action (Macek
et al., 1994). Lytic activity by EqtII requires the presence of
SM in cell membranes (Belmonte et al., 1993; Macek et al.,
1994) and the speciﬁc interaction of EqtII with SM warrants
further investigation.
It has been suggested that other SM-preferring cytolysins,
sticholysin I and II (Valcarcel et al., 2001), may form toroidal
pores (Yang et al., 2000; Yang et al., 2001), which have been
shown by neutron reﬂectivity (Gilbert et al., 1998), and by us
using solid-state NMR and EM (Bonev et al., 2000b, 2001a)
to occur during the action of the bacterial toxin pneumolysin.
At the concentrations of EqtII used in this study, the toxin is
likely to be predominantly in the monomeric state (Macek
et al., 1995; Tejuca et al., 1996) and pores would not be the
cause of the isotropic signal. The lipid-protein interaction that
we describe here is more likely related to non-pore activity of
the toxin, and no pores were observed in MLVs in our EM
studies. Our NMR results show that in the presence of SM
EqtII promotes formation of an isotropic lipid phase and slows
down lipid mobility, and the EM data show the formation of
small vesicles on the surface of MLVs as a consequence of
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the toxin disrupting the mixed-lipid bilayers. The toxin in the
remaining multilamellar structures appears to engage selec-
tively SM into lateral proteolipid domains surrounded by PC-
enriched lipidmatrix. Further NMR studies of labeled EqtII in
lipid bilayers are proposed in order to determine the location
of the toxin in the membrane.
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